Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies
Published on: May 26, 2023
ShcA expression in podocytes is dispensable for glomerular development but its upregulation is associated with kidney
1Department of Molecular and Cellular Biology, University of Guelph Guelph, ON, Canada.
Insights
ShcA (SHC1) protein is not essential for normal kidney function in mice. However, increased ShcA expression in podocytes is linked to kidney disease and proteinuria.
Area of Science:
- Molecular biology
- Nephrology
- Cell signaling
Background:
- ShcA (SHC1) is a key phosphotyrosine adaptor protein with vital cellular signaling roles.
- Embryonic ShcA loss is lethal; aberrant expression is linked to various diseases.
- ShcA is highly expressed in developing glomeruli and upregulated in podocytes during kidney injury and disease.
Purpose of the Study:
- To investigate the in vivo role of ShcA specifically within kidney podocytes.
Main Methods:
- Selective deletion of all ShcA isoforms in mouse podocytes using the Cre/lox system (Nphs2 promoter).
- Confirmation of ShcA deletion via immunostaining.
- Assessment of urinary albumin, glomerular morphology (light and electron microscopy), and SHC1 mRNA levels in human renal disease (Nephroseq database).
Main Results:
- Mice lacking podocyte ShcA showed normal development and no overt renal impairment up to one year of age.
- Increased ShcA mRNA expression in human kidneys correlated with proteinuria and reduced glomerular filtration rate.
Conclusions:
- Podocyte ShcA is dispensable for normal kidney function.
- Upregulation of ShcA is associated with kidney disease, suggesting a role in disease pathogenesis rather than normal physiology.
Background:
ShcA (SHC1) is a phosphotyrosine adaptor protein which plays broad signaling roles within the cell. Systemic loss of ShcA during embryogenesis is lethal, while its aberrant expression contributes to disease. We recently demonstrated that ShcA is highly expressed during glomerular development and that it is upregulated within podocytes in experimental kidney injury and chronic kidney disease. The objective of this study was to analyze the in vivo role of ShcA in podocytes.
Methods:
We selectively deleted all three isoforms of ShcA from mouse kidney podocytes using the Cre/lox system driven by the podocyte-specific podocin promoter (Nphs2). Immunostaining of kidney sections was used to confirm ShcA deletion in podocytes. Coomassie blue staining of protein gels was used to detect urinary albumin. Light and electron microscopy were used to assess glomerular morphology. Transcript levels of SHC1 in human renal disease were assessed using the Nephroseq database.
Results:
Mice lacking podocyte ShcA were born at the expected Mendelian frequency and did not display overt renal impairment or changes in podocyte architecture beyond one year of age. In parallel, we correlated increased ShcA mRNA expression in the human kidney with proteinuria and reduced glomerular filtration rate.
Conclusion:
Our studies reveal that ShcA is dispensable for normal kidney function, but its upregulation is associated with disease.
More Related Videos
08:06Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
Published on: July 2, 2020
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Cell Specific Gene Expression
Regulation of Hematopoietic Stem Cells